PharmaTher Holdings (XCNQ:PHRM) Interest Expense : C$0.00 Mil (TTM As of Aug. 2024)

View and export this data going back to 2021. Start your Free Trial

What is PharmaTher Holdings Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. PharmaTher Holdings's interest expense for the three months ended in Aug. 2024 was C$ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Aug. 2024 was C$0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. PharmaTher Holdings's Operating Income for the three months ended in Aug. 2024 was C$ -0.33 Mil. PharmaTher Holdings's Interest Expense for the three months ended in Aug. 2024 was C$ 0.00 Mil. PharmaTher Holdings has no long-term debt ⁽¹⁾. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

PharmaTher Holdings Interest Expense Historical Data

The historical data trend for PharmaTher Holdings's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaTher Holdings Interest Expense Chart

PharmaTher Holdings Annual Data

Trend

May21

May22

May23

Interest Expense

PharmaTher Holdings Quarterly Data
	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	Aug24
Interest Expense	Get a 7-Day Free Trial											-	-	-	-	-

PharmaTher Holdings Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

PharmaTher Holdings (XCNQ:PHRM) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

PharmaTher Holdings's Interest Expense for the three months ended in Aug. 2024 was C$0.00 Mil. Its Operating Income for the three months ended in Aug. 2024 was C$-0.33 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Aug. 2024 was C$0.00 Mil.

PharmaTher Holdings's Interest Coverage for the quarter that ended in Aug. 2024 is calculated as

PharmaTher Holdings had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

PharmaTher Holdings Ltd has no debt.

PharmaTher Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaTher Holdings Ltd (XCNQ:PHRM) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

PHRRF:USA

Address

82 Richmond Street East, Toronto, ON, CAN, M5C 1P1

Website

https://www.pharmather.com

PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch among others.

Executives

Fabio Chianelli

Director, Senior Officer

PharmaTher Holdings Headlines

No Headlines